Literature DB >> 15589421

COX-3: fact or fancy?

Francis Berenbaum.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15589421     DOI： 10.1016/j.jbspin.2004.02.003

Source DB:  PubMed          Journal:  Joint Bone Spine        ISSN： 1297-319X            Impact factor:   4.929


× No keyword cloud information.
  4 in total

1.  The NSAID roller coaster: more about rofecoxib.

Authors:  J K Aronson
Journal:  Br J Clin Pharmacol       Date:  2006-09       Impact factor: 4.335

Review 2.  Antiplatelet drug 'resistance'. Part 1: mechanisms and clinical measurements.

Authors:  Joseph M Sweeny; Diana A Gorog; Valentin Fuster
Journal:  Nat Rev Cardiol       Date:  2009-04       Impact factor: 32.419

3.  Regular adult aspirin use decreases the risk of non-small cell lung cancer among women.

Authors:  Alison L Van Dyke; Michele L Cote; Geoffrey Prysak; Gina B Claeys; Angie S Wenzlaff; Ann G Schwartz
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-01-09       Impact factor: 4.254

4.  Antinociceptive effect of tetrandrine on LPS-induced hyperalgesia via the inhibition of IKKβ phosphorylation and the COX-2/PGE₂ pathway in mice.

Authors:  Hengguang Zhao; Fuling Luo; Hongzhong Li; Li Zhang; Yongfen Yi; Jingyuan Wan
Journal:  PLoS One       Date:  2014-04-10       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.